KELLY KEEGAN: Open Payments
NPI 1528109295 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 31 payments from 15 companies in 2025. Trend: 2023 $366 · 2024 $404 · 2025 $803
Food & beverage: $787Education: $16
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 5 | $177 |
| Ardelyx, Inc. | 5 | $161 |
| AKEBIA THERAPEUTICS INC | 5 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Amgen Inc. | 2 | $56 |
| ANI Pharmaceuticals, Inc. | 2 | $45 |
| Novo Nordisk Inc | 1 | $26 |
| Vifor Pharma, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: Vafseo, Filspari, XPHOZAH 30 MG, IBSRELA, Kerendia, KRYSTEXXA, PURIFIED CORTROPHIN GEL, Ozempic.
Industry payments across PA — which companies pay providers there.
